Renaissance Technologies’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-910,301
Closed -$732K 3865
2020
Q2
$732K Buy
910,301
+121,300
+15% +$102K ﹤0.01% 2707
2020
Q1
$545K Buy
789,001
+33,333
+4% +$40.8K ﹤0.01% 2723
2019
Q4
$1.19M Buy
755,668
+44,400
+6% +$124K ﹤0.01% 2547
2019
Q3
$2.82M Buy
711,268
+97,362
+16% +$566K ﹤0.01% 2090
2019
Q2
$4.45M Buy
613,906
+550,506
+868% +$3.76M ﹤0.01% 1877
2019
Q1
$419K Buy
63,400
+33,471
+112% +$221K ﹤0.01% 2992
2018
Q4
$214K Buy
29,929
+21,267
+246% +$237K ﹤0.01% 3117
2018
Q3
$165K Buy
+8,662
New +$309K ﹤0.01% 3182
2017
Q2
Sell
-50,389
Closed -$3.65M 3471
2017
Q1
$3.65M Buy
50,389
+15,937
+46% +$1.05M 0.01% 1896
2016
Q4
$1.97M Buy
34,452
+5,580
+19% +$511K ﹤0.01% 2247
2016
Q3
$3.7M Buy
28,872
+20,940
+264% +$2.68M 0.01% 1796
2016
Q2
$988K Sell
7,932
-26,230
-77% -$3.02M ﹤0.01% 2547
2016
Q1
$2.86M Buy
+34,162
New +$2.82M 0.01% 2004
2015
Q3
Sell
-16,560
Closed -$2.54M 3483
2015
Q2
$2.54M Buy
16,560
+8,420
+103% +$1.39M 0.01% 1908
2015
Q1
$1.39M Buy
+8,140
New +$1.23M ﹤0.01% 2137
2014
Q1
Sell
-1,110
Closed -$194K 3118
2013
Q4
$194K Buy
+1,110
New +$191K ﹤0.01% 2628

Other funds holding ELGX

Renaissance Technologies's ELGX Position: Q3 2020 in Review

Renaissance Technologies sold out of Endologix Inc (ELGX) in Q3 2020, closing a stake of 910,301 shares — an estimated $732K sold.

Renaissance Technologies first reported a position in ELGX in Q4 2013 and held it in 16 quarters. The position peaked at $4.45M in Q2 2019. 6 funds tracked by Wall St. Rank hold ELGX as of Q3 2020.

  • Renaissance Technologies reported no remaining Endologix Inc position as of Q3 2020 after selling out during the quarter.
  • Renaissance Technologies sold 910,301 Endologix Inc shares in Q3 2020, an estimated $732K.
  • Renaissance Technologies first reported a position in Endologix Inc in Q4 2013 and held it in 16 quarters.
  • Renaissance Technologies's Endologix Inc position peaked at $4.45M in Q2 2019.
  • 6 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2020.

Based on Renaissance Technologies's 13F filing for Q3 2020, filed 13 Nov 2020.